Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement

Pediatrics

Volumn 120, Issue 1, 2007, Pages

  Calonge, Ned ^a   Petitti, Diana B ^b   DeWitt, Thomas G ^c   Gordis, Leon ^d   Gregory, Kimberly D ^e   Harris, Russell ^f   Kizer, Kenneth W ^g   LeFevre, Michael L ^h   Loveland Cherry, Carol ⁱ   Marion, Lucy N ^j   Moyer, Virginia A ^k   Ockene, Judith K ^l   Sawaya, George F ^m   Siu, Albert L ⁿ   Teutsch, Steven M ^o   Yawn, Barbara P ^p  

^a Colorado Department of Public Health and Environment ^*  (United States)

^b KAISER PERMANENTE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g NATIONAL QUALITY FORUM   (United States)

^h University of Missouri   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j MEDICAL COLLEGE OF GEORGIA   (United States)

^k UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^l UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ MOUNT SINAI MEDICAL CENTER   (United States)

^o MERCK RESEARCH LABORATORIES   (United States)

^p OLMSTED MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACCURACY; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; EXERCISE; FAMILIAL DISEASE; FAMILY HISTORY; HEALTH CARE ORGANIZATION; HUMAN; LIPID BLOOD LEVEL; LOW FAT DIET; MONOGENIC DISORDER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELIABILITY; REVIEW; SCREENING TEST; UNITED STATES; UNSPECIFIED SIDE EFFECT;

CHILD; DYSLIPIDEMIAS; HUMANS;

EID: 34447121242     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1812     Document Type: Review

References (19)

1. Lipid Research Clinics Program. Population Studies Data Book: The Prevalence Study. Vol 1. Washington, DC: Government Printing Office; 1980. DHHS publication No. (NIH) 80-1527.
2. Haney EM, Huffman LH, Bougatsos C, et al. Screening for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force. Portland, Oregon: Oregon Evidence-based Practice Center; 2007. AHRQ publication No. 07-0598-EF-1
3. Freedman DS, Shear CL, Srinivasan SR, Webber LS, Berenson GS. Tracking of serum lipids and lipoproteins in children over an 8-year period: the Bogalusa Heart Study. Prev Med. 1985;14:203-216
4. Kwiterovich PO Jr, Heiss G, Johnson N, Chase GA, Tamir I, Rifkind B. Assessment of plasma total cholesterol as a test to detect elevated low density (beta) lipoprotein cholesterol levels (type IIa hyperlipoproteinemia) in young subjects from a population-based sample. Am J Epidemiol. 1982;115:192-204
5. Shea S, Basch CE, Irigoyen M, et al. Failure of family history to predict high blood cholesterol among Hispanic preschool children. Prev Med. 1990;19:443-455
6. Dennison BA, Kikuchi DA, Srinivasan SR, Webber LS, Berenson GS. Serum total cholesterol screening for the detection of elevated low-density lipoprotein in children and adolescents: the Bogalusa Heart Study. Pediatrics. 1990;85:472-479
7. McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr. 1997;130:266-273
8. Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr. 1996;129:42-49
9. Obarzanek E, Kimm SY, Barton BA, et al. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics. 2001;107:256-264
10. DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: the Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group. JAMA. 1995;273:1429-1435
11. Shannon BM, Tershakovec AM, Martel JK, Achterberg CL, Cortner JA. Reduction of elevated LDL-cholesterol levels of 4-to 10-year-old children through home-based dietary education. Pediatrics. 1994;94:923-927
12. Davidson MH, Dugan LD, Burns JH, Sugimoto D, Story K, Drennan K. A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study. Am J Clin Nutr. 1996;63:96-102
13. McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med. 1998;152:1089-1094
14. Amundsen AL, Ose L, Nenseter MS, Ntanios FY. Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. Am J Clin Nutr. 2002;76:338-344
15. de Jongh S, Vissers MN, Rol P, Bakker HD, Kastelein JJ, Stroes ES. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis. 2003;26:343-351
16. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89:495-501
17. American College of Obstetricians and Gynecologists. Health Care for Adolescents. Washington, DC: American College of Obstetricians and Gynecologists; 2003
18. Kavey RE, Daniels SR, Lauer RM, et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003;107:1562-1566
19. McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115:1948-1967